viewimage / Shutterstock.com
13 June 2024NewsBiotechnologyMarisa Woutersen

Guardant Health files suit against Tempus AI

Biotech takes legal action against Tempus AI, alleging patent infringement in Tempus's liquid biopsy products | Complaint accuses Tempus of unauthorised use of Guardant's tech crucial for cancer diagnostics.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
1 February 2024   PTAB says claims of genetic disease testing patent are not obvious | Rival biotech firm denied petition for invalidation.
Americas
16 November 2023   TwinStrand Biosciences and the University of Washington win patent infringement case related to DNA mutation technology.